STENTYS to Present First Results of Sirolimus-eluting Self-Apposing® Stent at ... 4-traders (press release) STENTYS (Paris:STNT) (FR0010949404 - STNT), a medical technology company commercializing the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), today announced that the 4-month results of the APPOSITION IV trial ... |
